Hypoxia followed by reoxygenation (HR) and ischemia-reperfusion (IR) cause cell death in neonatal rat ventricular myocytes (NRVM) primarily through the generation of oxidative stress. Extracellular catalase (CAT) has not been effective in reducing or eliminating IR or HR-induced cell death due both to extracellular degradation and poor cellular uptake.
1) to determine if a cell penetrating catalase derivative with enhanced peroxisome targeting efficiency (catalase-SKL) increases intracellular levels of the antioxidant enzyme in NVRM; and 2) to determine if catalase-SKL protects against both HR and IR injury.
NRVM were subjected to 3 or 6 hr of HR or 1 hr of IR. CAT concentration, activity, and subcellular distribution were determined using standard techniques. Reactive oxygen species (ROS) and related oxidative stress were visualized using 2’,7’-dichlorofluorescin diacetate. Cell death was measured using trypan blue exclusion or lactate dehydrogenase (LDH) release assays.
CAT activity was higher in (catalase-SKL) transduced myocytes, was concentrated in a membranous cellular fraction, and potently inhibited oxidative stress. In contrast to non-transducible (unmodified) CAT, catalase-SKL-treated myocytes were protected against both HR and IR.
1) catalase-SKL increased myocyte CAT content and activity and dramatically increased resistance to hydrogen peroxide-induced oxidation; 2) catalase-SKL protects against both HR and IR; 3) catalase-SKL may represent a new therapeutic approach to protect hearts against myocardial HR or IR.